BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 4653423)

  • 21. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
    Spatz R; Kollmannsberger A
    Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
    [No Abstract]   [Full Text] [Related]  

  • 22. [Porta-systemic encephalopathy. A complication after portacavae shunt operation].
    Falch D; Forfang K
    Tidsskr Nor Laegeforen; 1971 Aug; 91(21):1522-5. PubMed ID: 5569809
    [No Abstract]   [Full Text] [Related]  

  • 23. [On portacaval encephalopathy. Apropos of 25 cases].
    NOUSSIAS MP
    Rev Med Moyen Orient; 1962; 19():341-52. PubMed ID: 14480516
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic encephalopathy evaluation.
    Delgado RL
    Lab Res Methods Biol Med; 1983; 7():587-601. PubMed ID: 6353114
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acidophilus milk in dietary treatment of liver cirrhosis with encephalopathy].
    Abrahamsson L; Bengtsson S; Hambraeus L; Ulwán O; Oberg G
    Nord Med; 1971 Aug; 86(33):969-73. PubMed ID: 4999372
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.
    Demedts M; Pillen E; De Groote J; Van de Woestijne KP
    Acta Neurol Belg; 1973; 73(5):281-8. PubMed ID: 4785018
    [No Abstract]   [Full Text] [Related]  

  • 27. Milk-and-cheese diet in portal-systemic encephalopathy.
    Fenton JC; Knight EJ; Humpherson PL
    Lancet; 1966 Jan; 1(7430):164-6. PubMed ID: 4159095
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic encephalopathies: opportunities and challenges.
    Lockwood AH
    J Cereb Blood Flow Metab; 1987 Oct; 7(5):523-6. PubMed ID: 3654793
    [No Abstract]   [Full Text] [Related]  

  • 30. [Porto-caval encephalopathy: contribution to the ultrastructural pathology of human glia].
    Foncin JF; Nicolaidis S
    Rev Neurol (Paris); 1970 Aug; 123(2):81-7. PubMed ID: 5516063
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and physiopathological study of hepatic encephalopathy].
    Spatz R; Kollmannsgerger A
    Minerva Med; 1972 Feb; 63(12):721-6. PubMed ID: 5012554
    [No Abstract]   [Full Text] [Related]  

  • 32. [The outlook for cirrhotic patients after porto-caval anastomosis].
    Quinton A; Bancons J
    Bord Med; 1971 Dec; 4(12):1581-604. PubMed ID: 5316986
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of peripheral and CNS biochemical changes in models of acute and chronic experimental hepatic insufficiency in the rat].
    Rosati R; Montorsi M; Beccaria G; Santambrogio R; Salerno F; Malesci A; Abbiati R; Bonato C; Spina GP
    Minerva Chir; 1983 Oct; 38(19):1489-92. PubMed ID: 6320059
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of severe liver diseases on the central nervous system].
    Rasenack U; Grün M; Liehr H
    Med Klin; 1977 Jan; 72(3):67-72. PubMed ID: 320440
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 37. [Morbidity in portacaval anastomosis: 27 cases].
    Schoofs E; Derom F; Berzsenyi G; Van Houtte R; D'Haveloose J; Van Hee W; Hamerijck M; De Vos M; Demeulenaere L
    Acta Gastroenterol Belg; 1971 Feb; 34(2):263-9. PubMed ID: 5565417
    [No Abstract]   [Full Text] [Related]  

  • 38. [Encephalomyelopathy caused by liver cirrhosis with termino-lateral portacaval anastomosis].
    Oliveras de la Riva C; Aragones JM; Teres J; Badrinas F; Bruguera M; Bonnin J; Rodes J; Gibert Queralto J
    Rev Neurol (Paris); 1967 Oct; 117(4):588-9. PubMed ID: 5609771
    [No Abstract]   [Full Text] [Related]  

  • 39. Precipitating factors in genesis of hepatic coma.
    Faloon WW; Evans GL
    N Y State J Med; 1970 Dec; 70(23):2891-6. PubMed ID: 5312239
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.